Evidence map›Paper›PMID 32868231›Full record

ArticleClinical colorectal cancer2021

Impact of COVID-19 Pandemic on Colorectal Cancer Screening Program.

Valeria D'Ovidio, Cristina Lucidi, Giovanni Bruno, Daniele Lisi, Lucia Miglioresi, Marco Emilio Bazuro

Open access · bronzeAbstract read
In one paragraph

Article in Clinical colorectal cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 4 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 4 syntheses or guidelines pooled it, 84 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Guideline
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Safety of Endoscopy Units during the COVID-19 Pandemic.GE Portuguese journal of gastroenterology · 2023
    Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Valeria D'OvidioGastrointestinal Endoscopy Unit, S. Eugenio Hospital, Rome, Italy. Electronic address: valeria.dovidio@aslroma2.it.
Cristina LucidiGastrointestinal Endoscopy Unit, S. Eugenio Hospital, Rome, Italy.
Giovanni BrunoGastrointestinal Endoscopy Unit, S. Eugenio Hospital, Rome, Italy.
Daniele LisiGastrointestinal Endoscopy Unit, S. Eugenio Hospital, Rome, Italy.
Lucia MiglioresiGastrointestinal Endoscopy Unit, S. Eugenio Hospital, Rome, Italy.
Marco Emilio BazuroGastrointestinal Endoscopy Unit, S. Eugenio Hospital, Rome, Italy.
St. Eugenio Hospital · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionOne of the main clusters of coronavirus disease-2019 (COVID-19) has been identified in Italy. Following European and local guidelines, Italian endoscopy units modulated their activity. We aimed at analyzing the need and safety to continue selective colorectal cancer screening (CRCS) colonoscopies during the COVID-19 pandemic. PATIENTS AND

methodsWe carried out a retrospective controlled cohort study in our "COVID-free" hospital to compare data of the CRCS colonoscopies of the lockdown period (March 9 to May 4, 2020) with those of the same period of 2019 (control group). A pre/post endoscopic sanitary surveillance for COVID-19 infection was organized for patients and sanitary staff.

resultsIn the lockdown group, 60 of 137 invited patients underwent endoscopy, whereas in the control group, 238 CRCS colonoscopies (3.9-fold) were performed. In the lower number of examinations during the lockdown, we found more colorectal cancers (5 cases; 8% vs. 3 cases; 1%; P = .002). The "high-risk" adenomas detection rate was also significantly higher in the "lockdown group" than in controls (47% vs. 25%; P = .001). A multiple regression analysis selected relevant symptoms (hazard ratio [HR], 3.1), familiarity (HR, 1.99), and lockdown period (HR, 2.2) as independent predictors of high-risk lesions (high-risk adenomas and colorectal cancer). No COVID-19 infections were reported among staff and patients.

conclusionsThe overall adherence to CRCS decreased during the pandemic, but the continuation of CRCS colonoscopies was efficacious and safe.

Indexed as

ColonoscopyEarly Detection of CancerSARS-CoV-2AgedColorectal NeoplasmsCOVID-19FemaleHumansMaleMiddle AgedPatient SafetyRetrospective StudiesAdenomaColonoscopyEndoscopyLockdownNeoplasticSARS-CoV-2

Identifiers

PMID32868231
PMCPMC7391078
OpenAlexW3046190048

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.